Literature DB >> 3475439

Further refinement and evaluation of intraoral vertical ramus osteotomy.

H D Hall, S J McKenna.   

Abstract

Eighty-nine patients were treated with a modified procedure for intraoral vertical ramus osteotomy. Complications were virtually eliminated except for damage to the inferior alveolar nerve. Acute nerve damage occurred in about 36% of operated sides. Seventy-four percent of these damaged nerves recovered fully by one year. Only 8% of operated sides had persistent diminished sensation, usually mild, of the lower lip and chin. It is concluded that this technique should be seriously considered for mandibular ramus osteotomies when the mandible is going to be retruded or minimally moved in any other direction.

Entities:  

Mesh:

Year:  1987        PMID: 3475439     DOI: 10.1016/0278-2391(87)90308-9

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  4 in total

1.  The study of position of antilingula, midwaist of mandibular ramus and midpoint between coronoid process and gonion in relation to lingula of 92 Thai dried mandibles as potential surgical landmarks for vertical ramus osteotomy.

Authors:  Wandee Apinhasmit; Supin Chompoopong; Pornchai Jansisyanont; Kwan Supachutikul; Natthapon Rattanathamsakul; Suthacha Ruangves; Sanjai Sangvichien
Journal:  Surg Radiol Anat       Date:  2010-07-16       Impact factor: 1.246

Review 2.  Orthognathic surgery and temporomandibular joint symptoms.

Authors:  Hwi-Dong Jung; Sang Yoon Kim; Hyung-Sik Park; Young-Soo Jung
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-05-28

3.  Antilingula as a Surgical Reference Point for Vertical Ramus Osteotomy.

Authors:  Han-Sheng Chen; Ying-Sheng Chen; I-Ling Lin; Chun-Feng Chen
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

4.  Correction of mandibular deficiency by inverted-L osteotomy of ramus and iliac crest bone grafting.

Authors:  Song-Song Zhu; Ge Feng; Ji-Hua Li; En Luo; Jing Hu
Journal:  Int J Oral Sci       Date:  2012-12-21       Impact factor: 6.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.